The new type of drug combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.
By ANDREW POLLACK, NY Times: Business
Fri, 02/22/2013 - 9:07am
The new type of drug combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.